Skip to Content


In the US, Integrilin (eptifibatide systemic) is a member of the drug class glycoprotein platelet inhibitors and is used to treat Acute Coronary Syndrome, Angina, Heart Attack and Percutaneous Coronary Intervention.

US matches:

UK matches:

Ingredient matches for Integrilin


Eptifibatide is reported as an ingredient of Integrilin in the following countries:

  • Australia
  • Belgium
  • Canada
  • Croatia (Hrvatska)
  • Cyprus
  • Czech Republic
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Iceland
  • Indonesia
  • Ireland
  • Italy
  • Kuwait
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Pakistan
  • Poland
  • Romania
  • Serbia
  • Singapore
  • Slovakia
  • South Africa
  • Spain
  • Sweden
  • Taiwan
  • Thailand
  • United Kingdom
  • United States

Eptifibatide acetate (a derivative of Eptifibatide) is reported as an ingredient of Integrilin in the following countries:

  • New Zealand

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.